Both in Pharmaceuticals
Nektar Therapeutics vs Omeros
Over the past year NKTR returned −35.7% and OMER returned +155.1%; their daily moves had a correlation of 0.16.
NKTR −35.7% OMER +155.1%Growth of $1, one year, split-adjusted
| Metric | NKTR | OMER |
|---|---|---|
| Price | $36.01 | $17.17 |
| Market cap | $1.23B | $1.24B |
| Today | −6.42% | −5.56% |
| 1 month | −10.6% | −8.4% |
| 6 months | −56.8% | +17.3% |
| Year to date | −14.8% | 0.0% |
| 1 year | −35.7% | +155.1% |
| Revenue growth (YoY) | −9.3% | — |
| Gross margin | 100.0% | 97.2% |
| Net margin | −401.0% | 46.4% |
| P/E (TTM) | — | 10.0× |
| Price / sales | 22.5× | 32.3× |
| Net cash | $684.3M | $58.7M |
| Dividend yield | — | — |
| Volatility (60d) | 70.8% | 77.7% |
| Short % of float | 21.0% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).